|
Catalog Number PXB35-08-57-135 |
Device Problem
Device Dislodged or Dislocated (2923)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/24/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that an attempt was made to use a visipro stent to treat a calcified lesion in the proximal iliac artery - common. degree of tortuosity was little. degree of calcification was severe.A 6fr terumo destination was used.A .035 glidewire advantage was used.Embolic protection was not used.Device was prepped per ifu. the lesion was pre-dilated with a 8mm x 40mm mustang pta. the device did not pass through a previously-deployed stent.Resistance was not encountered when advancing the device. stent dislodgement occurred, during removal following failed delivery.Stent was removed in conjunction with 6fr 45cm sheath. manual pressure on access site.No patient injury reported.
|
|
Manufacturer Narrative
|
Product analysis the device was returned with the stent separate, (photo 1).The balloon is in a pre-inflated state, (photo 3) and the stent is approximately 57mm with damage to the struts on none end, (photo 4).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|